Manulife (Manufacturers Life Insurance)’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-50,466
| Closed | -$12.5M | – | 3031 |
|
|
2022
Q3 | $12.5M | Sell |
50,466
-173
| -0.3% | -$46.7K | 0.01% | 723 |
|
|
2022
Q2 | $12.7M | Sell |
50,639
-450
| -0.9% | -$121K | 0.01% | 742 |
|
|
2022
Q1 | $16.9M | Buy |
51,089
+16,731
| +49% | +$5.15M | 0.01% | 709 |
|
|
2021
Q4 | $12.3K | Sell |
34,358
-8,079
| -19% | -$2.73M | 0.01% | 851 |
|
|
2021
Q3 | $13.8M | Sell |
42,437
-1,657
| -4% | -$561K | 0.01% | 791 |
|
|
2021
Q2 | $13.8M | Sell |
44,094
-608
| -1% | -$187K | 0.01% | 822 |
|
|
2021
Q1 | $14.2M | Sell |
44,702
-19
| -0% | -$6.08K | 0.01% | 801 |
|
|
2020
Q4 | $14.5M | Sell |
44,721
-2,836
| -6% | -$784K | 0.01% | 737 |
|
|
2020
Q3 | $13.2M | Sell |
47,557
-531
| -1% | -$153K | 0.01% | 682 |
|
|
2020
Q2 | $11.6M | Sell |
48,088
-956
| -2% | -$192K | 0.01% | 722 |
|
|
2020
Q1 | $7.12M | Buy |
49,044
+6,642
| +16% | +$1.1M | 0.01% | 863 |
|
|
2019
Q4 | $7.23M | Sell |
42,402
-2,510
| -6% | -$465K | 0.01% | 1023 |
|
|
2019
Q3 | $7.9M | Buy |
44,912
+3,031
| +7% | +$655K | 0.01% | 953 |
|
|
2019
Q2 | $10.9M | Sell |
41,881
-2,618
| -6% | -$695K | 0.01% | 788 |
|
|
2019
Q1 | $12.7M | Sell |
44,499
-189
| -0.4% | -$62.8K | 0.01% | 739 |
|
|
2018
Q4 | $14.5M | Buy |
44,688
+12,627
| +39% | +$4.39M | 0.02% | 610 |
|
|
2018
Q3 | $14.4M | Sell |
32,061
-16,661
| -34% | -$6.57M | 0.02% | 707 |
|
|
2018
Q2 | $19.9M | Sell |
48,722
-18,513
| -28% | -$6.71M | 0.02% | 590 |
|
|
2018
Q1 | $19.6M | Sell |
67,235
-2,287
| -3% | -$580K | 0.02% | 589 |
|
|
2017
Q4 | $13M | Buy |
69,522
+8,059
| +13% | +$1.5M | 0.01% | 739 |
|
|
2017
Q3 | $10.4M | Buy |
61,463
+1,565
| +3% | +$237K | 0.01% | 795 |
|
|
2017
Q2 | $8.58M | Buy |
59,898
+1,375
| +2% | +$185K | 0.01% | 906 |
|
|
2017
Q1 | $7.33M | Buy |
58,523
+3,501
| +6% | +$406K | 0.01% | 972 |
|
|
2016
Q4 | $6.2M | Buy |
55,022
+122
| +0.2% | +$14.1K | 0.01% | 982 |
|
|
2016
Q3 | $7.06M | Buy |
54,900
+1,688
| +3% | +$202K | 0.01% | 870 |
|
|
2016
Q2 | $5.82M | Sell |
53,212
-24,414
| -31% | -$2.43M | 0.01% | 944 |
|
|
2016
Q1 | $7.22M | Buy |
77,626
+50,360
| +185% | +$4.25M | 0.01% | 846 |
|
|
2015
Q4 | $2.46K | Buy |
27,266
+264
| +1% | +$22.4K | ﹤0.01% | 1349 |
|
|
2015
Q3 | $2.5K | Buy |
27,002
+661
| +3% | +$58.2K | ﹤0.01% | 1315 |
|
|
2015
Q2 | $1.73K | Buy |
26,341
+45
| +0.2% | +$2.99K | ﹤0.01% | 1453 |
|
|
2015
Q1 | $1.88K | Buy |
26,296
+856
| +3% | +$46.5K | ﹤0.01% | 1412 |
|
|
2014
Q4 | $968 | Sell |
25,440
-643
| -2% | -$20.3K | ﹤0.01% | 1596 |
|
|
2014
Q3 | $647 | Buy |
26,083
+789
| +3% | +$20K | ﹤0.01% | 1825 |
|
|
2014
Q2 | $636K | Sell |
25,294
-3,966
| -14% | -$92.3K | ﹤0.01% | 1879 |
|
|
2014
Q1 | $762 | Sell |
29,260
-237
| -0.8% | -$6.56K | ﹤0.01% | 1816 |
|
|
2013
Q4 | $789 | Sell |
29,497
-815
| -3% | -$20.1K | ﹤0.01% | 1759 |
|
|
2013
Q3 | $578 | Sell |
30,312
-925
| -3% | -$21.1K | ﹤0.01% | 1907 |
|
|
2013
Q2 | $673K | Buy |
+31,237
| New | +$628K | ﹤0.01% | 1697 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Manulife (Manufacturers Life Insurance)'s ABMD Position: Q4 2022 in Review
Manulife (Manufacturers Life Insurance) sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 50,466 shares — an estimated $12.5M sold.
Manulife (Manufacturers Life Insurance) first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $19.9M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Manulife (Manufacturers Life Insurance) reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 50,466 Abiomed Inc shares in Q4 2022, an estimated $12.5M.
- Manulife (Manufacturers Life Insurance) first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
- Manulife (Manufacturers Life Insurance)'s Abiomed Inc position peaked at $19.9M in Q2 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2022, filed 13 Feb 2023.